Factors affecting beta 2-microglobulin plasma concentration during hemodialysis.
We studied ten patients on hemodialysis (HD) treated in sequence with cuprophan (CU), ethylenevinylalcohol (EVAL), polyacrylonitrile (A-69) and polysulphone (PSP) membrane dialyzers. beta 2-microglobulin (beta 2m) was measured by radioimmunoassay in plasma and dialysate samples. Plasma concentrations were corrected for changes in extracellular volume (ECV). We also studied adsorption in vitro by incubating the above membranes with I-125-labelled beta 2m. There were no changes in beta 2m plasma concentration after HD with CU dialyzers, but a significant decrease was observed with the other membranes tested. Filtration of beta 2m across the dialyzer was absent with CU and minimal with EVAL. However, large amounts were recovered from dialysate with the high-permeability dialyzers, AN-69 and PSP. In vitro studies showed that maximal adsorption capacity was obtained with AN-69 (13%) compared to 9% with CU, 4% with EVAL and 7% with PSP. In summary, beta 2m clearance with PSP is achieved through greater removal of this protein by mass transport across the membrane. The mechanism by which beta 2m is removed from blood during AN-69 dialysis seems to include both adsorption to and filtration by the membrane itself.
Martin-Malo
A
A
Department of Nephrology, Reina Sofia Regional Hospital, University of Cordoba, Spain.
Mallol
J
J
Castillo
D
D
Barrio
V
V
Burdiel
L G
LG
Perez
R
R
Aljama
P
P
D000293:Adolescent; D000327:Adsorption; D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000209:etiology; D001672:Biocompatible Materials; D005260:Female; D006801:Humans; D007688:Kidneys, Artificial; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D001613:beta 2-Microglobulin / Q000032:analysis*
D001672:Biocompatible Materials; D008567:Membranes, Artificial; D001613:beta 2-Microglobulin